‘Digital twins’ to predict cancer treatment outcomes

International researchers have used ‘digital twins’ of real cancer patients to recreate clinical trials of new treatments. The approach uses a technology called FarrSight-Twin to run virtual clinical trials before testing new treatments on patients.

The approach could be used alongside clinical trials with a digital twin for each patient taking part, which together could form a control group for any trial. Ultimately, it might mean that patients could have different treatments tested on their digital twin to help select the most suitable treatment ahead of time. The research was…